Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

- Francis, Prudence A., Fleming, Gini F., Burstein, Harold J., Davidson, Nancy E., Geyer, Charles E., Walley, Barbara A., Ingle, James N., Coleman, Robert E., Müller, Bettina, Le Du, Fanny, Loibl, Sibylle, Winer, Eric P., Láng, István, Ruepp, Barbara, Loi, S, Colleoni, M, Coates, AS, Gelber, RD, Goldhirsch, A, Regan, MM, SOFT Investigators and the International Breast Cancer Study Group (a division of ETOP IBCSG Partners Foundation),, Ciruelos, Eva M., Bonnefoi, Hervé R., Bellet, Meritxell, Bernardo, Antonio, Climent, Miguel A., Martino, Silvana, Bermejo, Begoña

Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

- Pagani, Olivia, Walley, Barbara A., Stearns, Vered, Bonnefoi, Hervé R., Martino, Silvana, Geyer, Charles E., Chini, Claudio, Puglisi, Fabio, Spazzapan, Simon, Ruhstaller, Thomas, Winer, Eric P., Ruepp, Barbara, Fleming, Gini F., Loi, Sherene, Coates, AS, Gelber, RD, Goldhirsch, A, Regan, MM, Francis, Prudence A., SOFT and TEXT Investigators and the International Breast Cancer Study Group (a division of ETOP IBCSG Partners Foundation),, Colleoni, Marco, Láng, István, Gomez, Henry L., Tondini, Carlo, Burstein, Harold J., Goetz, Matthew P., Ciruelos, Eva M.

Adjuvant Therapy of Nivolumab Combined with Ipilimumab Versus Nivolumab Alone in Patients with Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)

- Weber, Jeffrey S., Schadendorf, Dirk, Ascierto, Paolo A., Sandhu, Shahneen, Eigentler, Thomas, Gutzmer, Ralf, Hassel, Jessica C., Robert, Caroline, Carlino, Matteo S., Di Giacomo, Anna Maria, Butler, Marcus O., Muñoz-Couselo, Eva, Del Vecchio, Michele, Brown, Michael P., Rutkowski, P, Haydon, A, Grob, J-J, Schachter, J, Queirolo, P, de la Cruz-Merino, L, van der Westhuizen, Andre, Menzies, AM, Re, S, Larkin, James, Bas, T, de Pril, V, Braverman, J, Tenney, DJ, Tang, H, Long, GV, Atkinson, Victoria, Schenker, Michael, Pigozzo, Jacopo, Gogas, Helen, Dalle, Stéphane, Meyer, Nicolas

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study

- Glasbey, James C., Nepogodiev, Dmitri, Simoes, Joana F. F., Omar, Omar, Li, Elizabeth, Venn, Mary L., Abou Chaar, Mohammad K., Capizzi, Vita, Chaudhry, Daoud, Desai, Anant, Edwards, Jonathan G., Evans, Jonathan P., Fiore, Marco, Videria, Jose Flavio, Ford, Samuel J., Ganly, Ian, Griffiths, Ewen A., Gujjuri, Rohan R., Kolias, Angelos G., Kaafarani, Haytham M. A., Pockney, Peter

Differential benefit of adjuvant docetaxel-based chemotherapy in patients with early breast cancer according to baseline body mass index

- Desmedt, Christine, Fornili, Marco, Sotiriou, Christos, Piccart, Martine, Biganzoli, Elia, Clatot, Florian, Demicheli, Romano, De Bortoli, Davido, Di Leo, Angelo, Viale, Giuseppe, de Azambuja, Evandro, Crown, John, Francis, Prudence A.

Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia: Results from a phase Ib/II study

- Wei, Andrew H., Strickland, Stephen A., Chyla, Brenda, Popovic, Relja, Salem, Ahmed Hamed, Agarwal, Suresh, Xu, Tu, Fakouhi, Kaffa M., Humerickhouse, Rod, Hong, Wan-Jen, Hayslip, John, Roboz, Gail J., Hou, Jing-Zhou, Fiedler, Walter, Lin, Tara L., Walter, Roland B., Enjeti, Anoop, Tiong, Ing Soo, Savona, Michael, Lee, Sangmin

Cancer Risks for PMS2-Associated Lynch Syndrome.

- Ten Broeke, Sanne W., van der Klift, Heleen M., Gallinger, Steven, Gomez Garcia, Encarna, Figueiredo, Jane C., Haile, Robert, Hampel, Heather L., Hopper, John L., Hoogerbrugge, Nicoline, von Knebel Doeberitz, Magnus, Le Marchand, Loic, Letteboer, Tom G. W., Tops, Carli M. J., Jenkins, MA, Lindblom, A, Lindor, NM, Mensenkamp, AR, Møller, P, Newcomb, PA, van Os, TAM, Pearlman, R, Pineda, M, Rahner, N, Aretz, Stefan, Redeker, EJW, Olderode-Berends, MJW, Rosty, C, Schackert, HK, Scott, Rodney, Senter, L, Spruijt, L, Steinke-Lange, V, Suerink, M, Thibodeau, S, Bernstein, Inge, Vos, YJ, Wagner, A, Winship, I, Hes, FJ, Vasen, HFA, Wijnen, JT, Nielsen, M, Win, AK, Buchanan, Daniel D., de la Chapelle, Albert, Capella, Gabriel, Clendenning, Mark, Engel, Christoph

Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial

- Porceddu, Sandro Virgilio, Bressel, Mathias, Collins, Marnie, Collins, Michael Kevin, Macann, Andrew Martin John, Milross, Christopher Gerard, Penniment, Michael Gordon, Liu, Howard Yu-hao, King, Madeleine Trudy, Panizza, Benedict James, Rischin, Danny, Poulsen, Michael Geoffrey, Stoneley, Adam, Veness, Michael John, Kenny, Lizbeth Moira, Wratten, Chris, Corry, June, Cooper, Stephen, Fogarty, Gerald Blaise

Participant-reported symptoms and their effect on long-term adherence in the International Breast Cancer Intervention Study I (IBIS-I)

- Smith, Samuel George, Sestak, Ivanka, Howell, Anthony, Forbes, John, Cuzick, Jack

Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer

- Catton, Charles N., Lukka, Himu, Tai, Keen Hun, Wu, Jackson S., Parliament, Matthew B., Tsakiridis, Theodoros, Corbett, Tom B., Tang, Colin, Dayes, Ian S., Warde, Padraig, Craig, Tim K., Julian, Jim A., Gu, Chu-Shu, Levine, Mark N., Martin, Jarad M., Supiot, Stéphane, Chung, Peter W. M., Bauman, Glenn S., Bahary, Jean-Paul, Ahmed, Shahida, Cheung, Patrick

Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor–positive, human epidermal growth factor receptor 2–negative early breast cancer: TEXT and SOFT Trials

- Regan, Meredith M., Francis, Prudence A., Pinotti, Graziella, Price, Karen N., Coates, Alan S., Goldhirsch, Aron, Gelber, Richard D., Pagani, Olivia, Fleming, Gini F., Walley, Barbara A., Viale, Giuseppe, Colleoni, Marco, Láng, István, Gómez, Henry L., Tondini, Carlo

Acute radiation skin toxicity associated with BRAF inhibitors

- Pulvirenti, T., Hong, A., Long, G. V., Wang, W., Clements, A., Forstner, D., Suchowersky, A., Guminski, A., McNeil, C., Hersey, P., Fogarty, G., Kefford, R.

Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial

- Ribi, Karin, Luo, Weixiu, Parmar, Vani, Tondini, Carlo, Kerbrat, Pierre, Perelló, Antonia, Neven, Patrick, Torres, Roberto, Lombardi, Davide, Puglisi, Fabio, Karlsson, Per, Ruhstaller, Thomas, Bernhard, Jürg, Colleoni, Marco, Coates, Alan S., Goldhirsch, Aron, Price, Karen N., Gelber, Richard D., Regan, Merideth M., Fleming, Gini F., Francis, Prudence A., Burstein, Harold J., Ciruelos, Eva, Bellet, Meritxell, Pavesi, Lorenzo, Lluch, Ana, Visini, Marilena

Anastrozole-induced carpal tunnel syndrome: results from the international breast cancer intervention study II prevention trial

- Spagnolo, Francesco, Sestak, Ivana, Howell, Anthony, Forbes, John F., Cuzick, Jack

Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V

- Colleoni, Marco, Sun, Zhuoxin, Goldhirsch, Aron, Price, Karen N., Karlsson, Per, Forbes, John F., Thürlimann, Beat, Gianni, Lorenzo, Castiglione, Monica, Gelber, Richard D., Coates, Alan S.

Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with pembrolizumab

- Hodi, F. Stephen, Hwu, Wen-Jen, Joshua, Anthony M., Hersey, Peter, Dronca, Roxana, Joseph, Richard, Hille, Darcy, Xue, Dahai, Li, Xiaoyun Nicole, Kang, S. Peter, Ebbinghaus, Scot, Perrone, Andrea, Kefford, Richard, Wolchok, Jedd D., Weber, Jeffrey S., Daud, Adil, Hamid, Omid, Patnaik, Amita, Ribas, Antoni, Robert, Caroline, Gangadhar, Tara C.

Low-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: International Breast Cancer Study Group Trial 22-00

- Colleoni, Marco, Gray, Kathryb P., Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D., Regan, Meredith M., Coates, Alan S., Price, Karen N., Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A., Gomez, Henry L., Linderholm, Barbro K., Puglisi, Fabio

Panel testing for familial breast cancer: calibrating the tension between research and clinical care

- Thompson, Ella R., Rowley, Simone M., Campbell, Ian G., Li, Na, McInerny, Simone, Devereux, Lisa, Wong-Brown, Michelle W., Trainer, Alison H., Mitchell, Gillian, Scott, Rodeny J., James, Paul A.

Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma

- Daud, Adil I, Wolchok, Jedd D., Joseph, Richard, Gangadhar, Tara C., Dronca, Roxana, Patnaik, Amita, Zarour, Hassane, Roach, Charlotte, Toland, Grant, Lunceford, Jared K., Li, Xiaoyun Nicole, Emancipator, Kenneth, Robert, Caroline, Dolled-Filhart, Marisa, Kang, S. Peter, Ebbinghaus, Scot, Hamid, Omid, Hwu, Wen-Jen, Weber, Jeffrey S., Ribas, Antoni, Hodi, F. Stephen, Joshua, Anthony M., Kefford, Richard, Hersey, Peter

Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence

- Chirgwin, Jacquie H., Giobbie-Hurder, Anita, Forbes, John F., Neven, Patrick, Láng, István, Colleoni, Marco, Thürlimann, Beat, Coates, Alan S., Price, Karen N., Ejlertsen, Bent, Debled, Marc, Gelber, Richard D., Goldhirsch, Aron, Smith, Ian, Rabaglio, Manuela